E-DRUG: Drug regulatory authority medicines registration software
----------------------------------------------------
Dear e-druggers,
I am looking for information about software that is presently, and successfully,
used by drug regulatory authorities (DRAs) for the registration of medicines (market allowances)
as well as to control the medicines already on the market (QC and batch tracking).
I assume that some countries have developed their own software and others have taken an off-the-shelve package.
I am aware of SIAMED but don't know of a country were it is implemented. Can anyone share their
experiences with this particular software (ease of use and maintenance of the database for example).
In Suriname, for example, a locally developed Access database is used.
E-DRUG: Drug regulatory authority medicines registration software (2)
---------------------------------------------------------
Dear colleagues,
The Ethiopian Drug Administration and Cotrol Authority of Ethiopia has been using SIAMED for long and my friends i the registration department found it user friendely in every aspect. Should you require further Information i will let you communicate with some of them.
E-DRUG: Pills, Patients, and Profits
------------------------------------
Dear E-druggers,
Subscribers may want to see the in-depth documentary by CTV on false claims of huge R&D costs by drug companies and suffering patients who cannot afford the unbearable prices. Personal case studies and expert critics make any one of the three segments useful for health policy courses.
CTV 4-part film March 2010 Great Case studies for class on inflated costs and suffering patients who can’t afford unjustified prices.
“W5 Investigates: Pills, Patients, and Profits.” w/ Victor Malareck.
E-DRUG: Pills, Patients, and Profits (2)
------------------------------
A compelling documentary on medicines profits based on artificial R&D costs. If these unchecked costs could be so common in a regulated Canadian drug industry, it questions my mind what the situation will be in a less regulated drug market.
On a recent visit to a registered pharmacy in Cameroon, Sub Sahara Africa, a common mouthwash sold in Canada for ~$5 was priced at ~$30CAD. When I asked the pharmacist why such a marked price increase she told me that I would have spared the visit to the pharmacy by bringing one directly from Canada. No wonder roadside and clandestine medicines might have come to stay in such communities due to the unaffordable pharmacy prices.
I thank Donald Light for shedding more light on pricing malpractice in the developed economies and wonder if the situation in the less developed economies could ever improve...
Kind regards.
Magnus A. Atemnkeng, PhD
magnusajong@yahoo.com
Montreal, Canada
Magnus Ajong <magnusajong@yahoo.com>
E-DRUG: Pills, Patients, and Profits (3)
----------------------------------------
Is there any paper on the accounting practices used to price AND value
intellectual property. Last time I looked they were similar to derivatives
(which caused the crash) in that they were arcane, based on so called
Chinese walls, and according to the tax justice network very very
susceptible to transfer pricing.
be grateful
riaz tayob
Seatini South Africa
Riaz Tayob <riaz.tayob@gmail.com>